devinitorg/iati-policy-markers huggingface dataset:
NIHR RIGHT 4: HIPCARE - a cluster randomised controlled trial with embedded process evaluation A UK and low-and-middle-income-country (LMIC) partnership that aims to improve quality-of-life for hip fracture patients and to reduce healthcare costs in India, the Philippines, Sri Lanka, Thailand and Vietnam. 
Older patients are particularly likely to break a bone (fracture) because of a fall from a standing height, as their bones are weakened by osteoporosis. These ‘fragility’ fractures have serious consequences; in the UK 25% of hip fracture patients die within a year and survivors have a reduction in their quality-of-life similar to having a stroke. Outcomes may be even worse in LMIC without the same level of healthcare resource. Asia is particularly affected by rapidly ageing populations. The number of hip fractures is expected to increase from 1,124,060 now to 2,563,488 in 2050. Associated healthcare cost may rise to US$15 billion. Improving care for patients with hip fracture is therefore a priority in this region. 
Looking after patients following a hip fracture requires healthcare workers from many different backgrounds to work together. These include surgeons, doctors specialising in looking after older patients, nurses and therapists, each with defined roles and responsibilities. In the UK, this team approach has reduced the number of patients dying and improved quality-of-life after hip fracture. It also reduced time spent in hospital and associated healthcare costs. 
This study is about testing the benefits of such ‘multidisciplinary’ care in 5 LMIC in South Asia. To optimise the care, hospitals will receive a training package called HIPCARE. After refining the training materials to make HIPCARE specific to each country, we will do a large study to compare HIPCARE with usual care in 40 hospitals in LMIC in South Asia. The main aim is to improve the quality of life of patients after they have broken their hip and to reduce healthcare costs in low-and-middle-income-countries (LMIC). The project will have two principal objectives: 
1. To prepare the HIPCARE training package for each different country taking into account their specific healthcare system. 
2. To run a study to compare the quality of life of hip fracture patients who have been treated in a hospital where the HIPCARE training package has been introduced with patients who have been treated in a hospital that follows its standard care. 
Within the study, the following seven outcomes will be compared between patients treated in HIPCARE hospitals and patients treated in Standard Care hospitals. The outcomes will be measured up to 4 months after hip fracture surgery: 
1) Quality of Life 
2) Mortality rate 
3) Mobility Status 
4) The need of residential care 
5) Complication rate 
6) Healthcare and resource needs 
7) Cost effectiveness of the trial treatments 
These comparisons will be made for each country individually as well as for all countries together. In addition, this study will create a long-lasting research collaboration and sustainable infrastructure that can be used to facilitate future service improvements in each LMIC.
NIHR RIGHT 5: Adaptations to strengthen healthcare delivery and resilience to extreme weather events in Southern Africa (ASTRA) A UK and low-and-middle-income-country (LMIC) partnership jointly led by the University of Sussex and The Aurum Institute, South Africa. Starting in January, 2024, the four-year project aims to evaluate interventions to strengthen community and health system resilience to extreme weather events on vulnerable populations living with human immunodeficiency virus (HIV) and/or tuberculosis in Mozambique, South Africa and Zambia. These three countries are exposed to recurrent extreme weather events resulting in injuries, loss of lives, damage to infrastructure, including of healthcare facilities, often resulting in their inability to provide care during these extreme events.

The research findings will be analysed with stakeholders to develop interventions and policies that will be evaluated for their effectiveness in increasing the resilience of healthcare facilities during extreme weather events. The project has nine objectives: 

1. Systematically engage communities, health service implementers, and policymakers from health determining sectors to prioritise needs and design interventions/adaptations to strengthen health service delivery in the context of extreme weather events.

2. Undertake community and health service delivery vulnerability and adaptive capacity assessments to establish health-related extreme weather events vulnerability baseline in study countries.

3. Develop system dynamics models to evaluate the impact of co-created interventions for improving health system resilience.

4. Quantify the value for money of identified interventions.

5. Strengthen existing partnership between the University of Sussex, Africa Health Research Institute, South Africa, Zambart, Zambia and the London School of Hygiene and Tropical Medicine and extend the partnership to include the two Aurum institutes, civil society (Groundwork) and industry (Black box and Pista).

6. Develop a sustainable network of researchers with expertise in climate and health research.

7. Train the next generation of researchers and foster research leadership on climate change and health.

8. Educate the health workforce about climate change and impact on human health to better prepare the health system to respond during extreme weather events.

9. Facilitate South-South and North-South sharing of best practice in research and advocacy in climate change and health.
NIHR Global Health Research Centres: Learning Research Partner A UK and low-and-middle-income-country (LMIC) partnership that aims to support, embed and advance best-in-class methodological approaches - spanning MEL, research on research, and continuous improvement - across the lifetime of the Centres programme. The Learning Research Partner (LRP) will support all five (5) GHR Centres and stakeholders to develop and implement equitable and participatory MEL approaches including facilitating training and learning opportunities. This project has four objectives:

a. Exemplify the value of equitable and participatory monitoring, evaluation and learning approaches through supporting the Centres, providing insights of good practice and facilitating the design and delivery of training activities.

b. Work with Centres award-holders and NIHR programme teams to design and set up sustainable routes to enable shared learning and engagement in research capacity strengthening (RCS), community engagement and involvement (CEI), knowledge management etc. through e.g. learning, training platforms, networking events, workshops, seminars and/or other events.

c. Facilitate the development of an overarching programme-level Centres monitoring, evaluation and learning framework and strategy which is contextually-relevant and which both incorporates and supports Centres’ own development of participatory monitoring, evaluation and learning strategies and approaches at local level.

d. Work collaboratively with Centres award-holders and wider partners to consider which topics are suitable for formal ‘research on research’ studies across the
programme, and consider potential for research training of individuals (e.g. via LMIC-based PhD studentships).
National Institute for Health and Care Research (NIHR)’s second Global Research Professorship call National Institute for Health and Care Research (NIHR)’s second Global Research Professorship call. The Global Research Professorships programme funds research leaders, with a track-record of applied health research in low- and middle-income countries (LMICs), to promote effective translation of research and to strengthen research leadership at the highest academic levels. Funding of up to £2m over up to 5 years is awarded to Professors working in close partnership with a research institution in an LMIC. By the end of the award, NIHR Global Research Professors will be expected to: 

1) Have demonstrated research leadership at a national and/or international level.
2) Have been developed and protected by their institutions, including being relieved of administrative tasks.
3) Enhance existing and establish new research collaborations in low- and middle-income countries (LMICs).
4) Have supported training and capacity strengthening/mentorship within LMIC and UK (if applicable) institutions that enhances research capacity for future global health and care research.
NIHR RIGHT1: Social Sciences for Severe Stigmatising Skin Diseases (the 5-S Foundation) A UK and low- and middle-income country (LMIC) research partnership, Social Sciences for Severe Stigmatising Skin Diseases (5S) Foundation aims to fill gaps between knowledge, treatment and practice around three diseases, podoconiosis, mycetoma and scabies, working in Ethiopia, Sudan and Rwanda. 1. To examine the cultural logics and social and economic contexts of podoconiosis, mycetoma and scabies;
2. To understand the dynamics and dimensions of stigma;
3. To investigate how all three diseases have been conceptualised at national and international policy levels;
4. To evaluate existing interventions using social science perspectives;
5. To refine the conceptual framework developed to guide the Foundation’s research;
6. To develop a comprehensive intervention strategy for each disease;
7. To support endemic-country training posts (PhD and postdoctoral) in a manner that will leave enduring capacity or social science research;
8. To facilitate South-South and North-South sharing of best practice in research and advocacy applicable to a wide range of stigmatising conditions in low-resource settings.
Research for Health in Humanitarian Crises (R2HC) phase 4 The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The aim of the Research for Health in Humanitarian Crises (R2HC) programme is to develop more effective responses to humanitarian challenges by providing significant funding for high-quality research on the effectiveness of health interventions in humanitarian crises. The expected impact of the programme is that mortality, morbidity and suffering are reduced in humanitarian crises through demonstrated improvements in humanitarian and public health interventions. The expected outcome is that evidence from R2HC funded research positively influences the public health policies and practices of key humanitarian actors.
The programme has four output areas:
- Priority research gaps and needs are identified in response to demand from humanitarian health practitioners and policy makers
- Collaborative research partnerships are funded to generate research addressing priority health evidence gaps and supported to achieve uptake of findings
- Knowledge and learning from the R2HC portfolio of work is synthesised and shared in response to demand from practitioners and policy makers
- Key humanitarian stakeholders have access to and are informed of key evidence through strategic engagement and communications
European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2020 work plan The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2020 Workplan focussed on: ‘Mobilisation of funding for COVID-19 research in sub-Saharan Africa’; ‘Addressing gender and diversity gaps in clinical research capacity at the EDCTP Regional Networks of Excellence; and "Capacity development for disease outbreak and epidemic response in sub-Saharan Africa, in collaboration with Africa Centres for Disease Control and Prevention (Africa CDC)". This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2). The activities of the EDCTP2 programme will contribute towards achieving the following five specific objectives: Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance.
Biomedical Resources Grant: Harmonisation and Sharing of Linked HIV Cohort Data from Communities and Clinics in Africa The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR is providing support to a grant awarded under the Wellcome Trust's Biomedical Resources programme looking at the harmonisation and sharing of linked HIV cohort data from communities and clinics in Africa. 1) The new data resource will bridge population-based HIV surveillance in the network for Analysing Longitudinal Population-based HIV data in Africa (ALPHA) and clinical monitoring in the network for International Epidemiologic Databases to Evaluate AIDS (IeDEA), ensuring that data on people who participate in both ALPHA and IeDEA cohorts is exchangable and shared across the two networks. HIV clinics serving ALPHA sites but not currently part of IeDEA will be supported to attain data management standards required for IeDEA membership, using the international standard HIV Cohort Data Exchange Protocol (HICDEP) to ensure global data comparability. 2) The resource will provide robust, population-based data for all stages of the HIV care continuum from infection to viral suppression, enabling empirical monitoring of all three UNAIDS 90-90-90 goals, which neither network can do independently. It will automate and document the creation of standardised analytical datasets, extending the Centre-in-a-box methodology pioneered by the INDEPTH network. Data integration software will build and document transformations for compiling each site’s data into harmonised formats required for pooled datasets. Key summary statistical updates will be disseminated regularly through ALPHA web pages. Pooled datasets will be archived in the INDEPTH "iShare" public repository using the Data Documentation Initiative standard.
NIHR HPSR-DA: Improving equitable access to essential medicines in Ghana through bridging the gaps in implementing medicines pricing policy Availability of affordable medicines is critical for any national health system to ensure equitable access to healthcare. Medicine prices in Ghana are high compared to international reference prices. Between 2012 and 2017, the Government of Ghana introduced four major policies to regulate and reduce medicine prices. These policies are at different stages of implementation and to-date have not yielded the anticipated outcome. Our core focus is to understand, together with policymakers, why these presumed effective policies are not producing anticipated effects on medicine price reduction. Then - drawing on available published evidence and our understanding of how and why the policies are not effective in Ghana – we will co-develop a feasible action plan to facilitate implementation of these policies and generate a policy-driven research agenda to inform and address the information needs of policy makers. Our core question is “Why are these presumed effective medicine price control policies not producing the anticipated effects in implementation in the Ghanaian context?” 1) Develop an in-depth understanding of major determinants of effectiveness of implementing medicine pricing policies in different contexts
2) Develop a shared understanding of main facilitators and barriers to the implementation of medicine pricing policies in the Ghanaian context
3) Drawing on the results of No1 and 2, facilitate: (a) development of a feasible action plan to improve implementation of the four key policies to improve access to essential medicines and (b) coproduction of policy-relevant research agenda to address the information needs of key policymakers
NIHR HPSR-DA: Supporting the design of a whole system approach to facilitate the baby friendly community initiative in the Kenyan health system This project aims to build capacity & strengthen understanding of stakeholder research needs to facilitate the effective functioning of the Baby Friendly Community Initiative (BFCI; a community-based public health programme supporting health, growth & development of infants) within African primary care health systems. Members of our team have shown the BFCI’s efficacy within a randomised controlled trial (RCT) in Kenya and the Kenyan government is committed to scaling the BFCI. The challenge of this transition from RCT to scale is to embed the programme effectively into the health system working with existing resources. Engage with community, national and regional stakeholders to;
1) Share understanding of the BFCI 
2) Identify needs for research and develop a whole systems-based strategy for the BFCI uptake and dissemination in Kenya and into other African health systems
3) Build capacity in health economics and systems science between the UK & Kenyan teams.
NIHR Global Health Research Group on Preterm Birth Prevention and Management (PRIME) A UK and low- and middle-income country (LMIC) partnership that aims to address the challenges of preterm birth in LMICs, where its prevalence is highest. 1) Synthesise current knowledge and define the evidence gap in low and middle income countries (LMICs) regarding the prevalence, pattern, and perinatal management of pre-term birth (PTB)  2) Carry out a series of network research events to focus on understanding differential access, experiences and outcomes in advantaged and deprived populations. 3) Determine a research agenda (immediate, medium-, and long-term) relevant to each LMIC, to be developed/implemented during the term of the project and beyond. 4) Develop prenatal and postnatal evidence- based multi-professional guidelines for perinatal care for PTB. 5) Carry out pilot studies on term and preterm placentas to improve understanding of the contribution of these specific, often endemic, infections in LMICs to PTB in order to inform new research priorities around prevention of, and screening for identified infections. 6) Carry out vaginal swab studies in partner LMICs and explore at stakeholder-led research prioritisation exercises whether future studies of cervical electrical impedance spectroscopy (EIS) devices would be feasible, practical and acceptable in LMICs contexts. 7) Work directly with the Project Management Group to provide patient and public involvement (PPI) input into all project matter. 

Following a costed extension, additional objectives will include:
Work Package 1: Work with families, health care workers and policy planners.
1. Design and carry out pilot/ feasibility studies of interventions to improve adolescent sexual reproductive health (SRH), prevent unintended pregnancy, and reduce miscarriage, preterm birth (PTB), and “small for dates” in three locations.
2. Develop need-based and culturally sensitive intervention packages to improve adolescent SRH, antenatal care (ANC) and nutrition.
3. Test the feasibility of implementation, health systems integration, geographical scale-up and sustainability of these interventions.

Work Package 2: Employ metagenomics/ transcriptomics to identify viral pathogens in preterm vs. term placental tissues already collected from UK and Bangladesh women by 03/2021.

Work Package 3: Bridge the gap between research findings, policy and practice.
1. Implement PRIME (PReterm bIrth prevention and manageMEnt) research outputs (PTB guidelines, education and training resources by engagement/ advocacy workshops with families, healthcare workers, policy planners, and non-government organisations.
2. Systematically capture the impact of PRIME research outputs.
NIHR HPSR-DA: Essential diagnostics: developing methods, guidelines and capacity for effective national programmes The World Health Organization (WHO) has set up the Essential Diagnostics List (EDL) to complement the established Essential Medicine List (EML). Point of care diagnostics are increasingly available and affordable and have great potential. WHO decisions can put tests on the agenda, but countries need to consider whether they wish to purchase them, their role in the health system, and the development of feasible and effective standardised care pathways. These decisions require a range of specific scientific and local knowledge to inform their decisions on policy changes. We aim to develop an evidence-based approach to guide the adaptation of the WHO EDL to national health system needs and establish a Research Initiative for Evidence-based diagnostics in Africa. We will start this process by engagement with decision makers in health policy and practice in East Africa to jointly decide on information needs, methods and capacity. 1) Map access to trauma care as a complex health system problem 
2) Collect data from patients on their experiences of barriers to and quality of care 
3) Build research capacity in partner countries to enable further work 
4) Develop a network of trauma researchers 
5) Convene a meeting of investigators, patient representatives, and policy makers to discuss findings and, in combination with ongoing studies and literature review results, identify and agree upon priorities for a programme for future research